Mid-Morning Market Update: Markets Edge Higher; Tesla Q4 Deliveries Top Estimates

Benzinga2022-01-04

Following the market opening Monday, the Dow traded up 0.11% to 36,378.68 while the NASDAQ rose 0.18% to 15,673.75. The S&P also rose, gaining 0.11% to 4,771.56.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 56,142,170 cases with around 847,400 deaths. India confirmed a total of at least 34,922,880 cases and 481,890 deaths, while Brazil reported over 22,293,220 COVID-19 cases with 619,170 deaths. In total, there were at least 290,705,240 cases of COVID-19 worldwide with more than 5,461,870 deaths.

Leading and Lagging Sectors

Energy shares climbed 1.9% on Monday. Meanwhile, top gainers in the sector included Centrus Energy Corp. (NYSE:LEU), up 12% and Peabody Energy Corporation (NYSE:BTU) up 11%.

In trading on Monday, health care shares fell 1.5%.

Top Headline

Tesla, Inc. (NASDAQ:TSLA) reported record quarterly and annual deliveries that exceeded the most optimistic Wall Street forecasts.

Tesla's fourth-quarter deliveries came in at 308,600 units, the company said in a statement on Sunday. This represented a roughly 28% quarter-over-quarter increase from the 241,300 cars delivered in the third quarter. On a year-over-year basis, the change was about 71%.

Equities Trading UP

Immix Biopharma, Inc. (NASDAQ:IMMX) shares shot up 101% to $7.18. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.

Shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) got a boost, shooting 51% to $3.34. The stock may be seeing increased interested from retail investors.

Pear Therapeutics, Inc. (NASDAQ:PEAR) shares were also up, gaining 40% to $8.69. BTIG initiated coverage on Pear Therapeutics with a Buy rating and announced a price target of $12.

Check out these big movers of the day

Equities Trading DOWN

Applied Therapeutics, Inc. (NASDAQ:APLT) shares tumbled 30% to $6.28. Following discussions with the FDA, Applied Therapeutics decided to hold on submitting a marketing application for AT-007 for Galactosemia pending additional talks with the agency.

Shares of uCloudlink Group Inc. (NASDAQ:UCL) were down 17% to $5.44 after climbing 32% on Friday.

Himax Technologies, Inc. (NASDAQ:HIMX) was down, falling 12% to $14.00.

Commodities

In commodity news, oil traded up 1.4% to $76.24, while gold traded down 0.1% to $1,826.80.

Silver traded down 0.1% Monday to $23.325 while copper rose 0.1% to $4.4650.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 0.6%, while Spain’s IBEX 35 Index gained 0.8%. The German DAX gained 0.9%, French CAC 40 surged 1.1% and Italy’s FTSE MIB Index jumped 1%.

The IHS Markit Eurozone manufacturing PMI was confirmed at 58 for December, recording weakest level since February. French manufacturing PMI rose to 55.6 in December from a preliminary reading of 54.9, while German manufacturing PMI fell to 57.4 in December from a preliminary level of 57.9. The IHS Markit Spain manufacturing PMI declined to 56.2 in December versus 57.1 a month ago.

Economics

The IHS Markit manufacturing PMI was revised lower to 57.7 in December from a preliminary reading of 57.8.

US construction spending rose 0.4% for November.

The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.

Check out the full economic calendar here

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1